Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006–17): impact on susceptibility to first-line strategies | Zendy

Pierre Frange | Zendy; Véronique Avettand-Fènoël | Zendy; Florence Veber | Zendy; Stéphane Blanche | Zendy; MarieLaure Chaix | Zendy

Open Access

Prevalence of drug resistance in children recently diagnosed with HIV-1 infection in France (2006–17): impact on susceptibility to first-line strategies

Author(s) -

Pierre Frange,

Véronique Avettand-Fènoël,

Florence Veber,

Stéphane Blanche,

MarieLaure Chaix

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky203

Subject(s) - rilpivirine , etravirine , dolutegravir , efavirenz , nevirapine , medicine , elvitegravir , raltegravir , virology , drug resistance , atazanavir , integrase inhibitor , coinfection , genotyping , pediatrics , genotype , human immunodeficiency virus (hiv) , viral load , biology , antiretroviral therapy , genetics , gene

To describe the prevalence of transmitted drug resistance (TDR) among 84 children newly diagnosed with HIV in France in 2006-17.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research